Thema
Hepatitis C virus
Journal Article
12
Extrahepatic manifestations
3
China
2
Cirrhosis
2
Costs
2
Fibrosis
2
Glecaprevir
2
Liver disease
2
Review
2
Sofosbuvir
2
ALBI grade
1
Adherence
1
Alfosbuvir
1
Antiviral therapy
1
Beliefs about Medicines
1
CYP3A4
1
Child–Pugh class
1
Clinical/economic burden
1
Compensated cirrhosis
1
Daclatasvir
1
Decompensated cirrhosis
1
Direct-acting antivirals
1
Drug–drug interactions
1
Early treatment
1
Elimination
1
Fentanyl
1
Genotype 2
1
HIV virus
1
Harm reduction
1
Health-related quality of life
1
Hepatitis B virus
1
Infectious diseases
1
Intravenous drug abuse
1
Karnofsky performance status
1
Ledipasvir
1
Linkage to care
1
Liver mortality/morbidity
1
Modeling
1
Opioids
1
Pangenotypic direct-acting antivirals
1
People who inject drugs
1
Physiologically based pharmacokinetic model
1
Pibrentasvir
1
Risk factors
1
Sustained virologic response
1
Sustained virological response
1
Treatment naïve
1
Vaccination
1
Velpatasvir
1